1 Oct 2021; Company Announcement – Novant Health – Acrobat pdf 114k


  • PME signs 7-year, A$40M deal with Novant Health
  • Visage to replace multiple legacy PACS
  • Contract includes Visage 7 Workflow, in addition to Visage 7 Viewer
  • Visage 7 platform to be fully implemented in the public cloud
  • Extends PME’s rapidly growing footprint in the North American IDN market
  • Transaction based licence model with potential upside

Leading health imaging company Pro Medicus Limited [ASX: PME] today announced its wholly owned U.S. subsidiary, Visage Imaging, Inc., has signed a $40M, 7-year contract with Novant Health, Inc. (“Novant Health”).

Based on a transactional licensing model, the contract will see the company’s Visage 7 Enterprise Imaging Platform (“Visage 7”) and Visage 7 Workflow module implemented throughout Novant Health, providing a unified diagnostic imaging platform across the network.

Novant Health, headquartered in North Carolina, is a community-based integrated delivery network (IDN) that spans three U.S. states, including 15 medical centers and hundreds of outpatient facilities and physician clinics. Novant Health serves more than 6 million patients annually.

Planning for the rollout is to commence immediately, with initial go-lives targeted for the second half of the financial year. The implementation will be fully deployed in the Microsoft Azure cloud.

“Novant Health is our seventh major North American contract in less than 18 months and our equal largest deal to date, underpinning the strong momentum we continue to build in the market,” said Pro Medicus CEO Dr Sam Hupert.

“Like several of our other recent deals, it includes more than one of our products, in this case, Visage 7 Workflow as well as Visage 7 Viewer, validating our strategy of providing clients maximum flexibility by offering a highly modular, multi-product solution.”

Novant Health also joins an increasing number of Visage clients to opt for a fully cloud-based solution, a trend that is growing rapidly amongst healthcare providers in North America.

“Our pipeline remains strong. Deals like this confirm our view that Visage 7, with its proven cloud-native technology and modular design, provides us with a significant strategic advantage that enables us to address opportunities across a growing segment of the market both in North America and other regions,” said Dr Hupert.